The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.
Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback